35. 3.8 million people in England now have
diabetes-Gov.uk. Accessed 28th May 2020.
36. Statistics about diabetes-American diabetes association. Accessed
29th May 2020.
37. Knapp S. Diabetes and infection: is there a link? - a mini-review.Gerontology . 2013; 59: 99-104.
38. Schoen K, Horvat N, Guerreiro NFC, de Castro I, de Giassi KS.
Spectrum of clinical and radiographic findings in patients with diagnosis of H1N1 and
correlation with clinical severity. BMC Infect Dis. 2019;19(1):964.
39. Yang JK, Feng Y, Yuan MY, Yuan SY, Fu HJ, Wu BY, et al. Plasma
glucose levels and diabetes are independent predictors for mortality and morbidity in
patients with SARS. Diabet Med. 2006;23(6):623-8.
40. Banik GR, Alqahtani AS, Booy R, Rashid H. Risk factors for severity
and mortality in patients with MERS-CoV: Analysis of publicly available data from Saudi
Arabia. Virol Sin. 2016;31(1):81-4.
41. Wang A, Zhao W, Xu Z, Gu J. Timely blood glucose management for the
outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed. Diabetes
Res Clin Pract 2020: 108118.
42. Zhou J, Tan J. Diabetes patients with COVID-19 need better care.
Metabolism 2020: 154216.
43. Iqbal A, Prince LR, Novodvorsky P, Bernjak A, Thomas MR, Birch L, et
al. Effect of Hypoglycemia on Inflammatory Responses and the Response to Low-Dose
Endotoxemia in Humans. J Clin Endocrinol Metab. 2019; 104(4):1187-99.
44. Sardu C, D’Onofrio N, Balestrieri ML, et al. Outcomes in Patients
With Hyperglycemia Affected by Covid-19: Can We Do More on Glycemic Control?
Diabetes care 2020;
https://doi.org/10.2337/dc20-072345. Honce R, Schultz-Cherry S. Impact of obesity on influenza a virus
pathogenesis, immune response, and evolution. Front Immunol 2019;
10: 1071.
46. Huttunen R, Syrjänen J. Obesity and the risk and outcome of
infection. Int J Obes (Lond) 2013; 37: 333-40.
47. Dixon AE, Peters U. The effect of obesity on lung function.
Expert Rev Respir Med 2018; 12: 755-67.
48. Klein OL, Aviles-Santa L, Cai J, et al. Hispanics/Latinos with type
2 diabetes have functional and symptomatic pulmonary impairment
Mirroring kidney microangiopathy: findings from the Hispanic community
health Study/Study of Latinos (HCHS/SOL). Diabetes Care 2016; 39: 2051-7.
49. Esler M, Esler D. Can angiotensin receptor-blocking drugs perhaps be
harmful in the COVID-19 pandemic? J Hypertension 2020; doi:
10.1097/HJH.0000000000002450.
50. Gurwitz D. Angiotensin receptor blockers as tentative SARS-CoV-2
therapeutics. Drug Dev Res. 2020. doi: 10.1002/ddr.21656.
51. Sinclair AJ, Abdelhafiz AH.
Age,
frailty and diabetes – triple jeopardy for vulnerability to COVID-19
infection. EClinicalMedicine 2020;
doi.org/10.1016/j.eclinm.2020.100343.